Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lifetime Impact Study for Achondroplasia (LISA)

NCT03872531 is registered in ClinicalTrials.gov with BioMarin Pharmaceutical as lead sponsor.

NCT NCT03872531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03872531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lifetime Impact Study for Achondroplasia (LISA)
Lead sponsor
BioMarin Pharmaceutical
Phase
Observational
Overall status
Completed
Start date
March 31, 2019
Completion date
February 6, 2021
Enrollment
173 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

achondroplasia